Skip to main content
Top
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Research article

Long-term mortality among women with epithelial ovarian cancer: a population-based study in British Columbia, Canada

Authors: Nimisha Arora, Aline Talhouk, Jessica N. McAlpine, Michael R. Law, Gillian E. Hanley

Published in: BMC Cancer | Issue 1/2018

Login to get access

Abstract

Objectives

Among women with epithelial ovarian cancer (EOC), histotype is one of the major prognostic factors. However, few data are available on histotype- specific survival and mortality estimates among these patients. We therefore examined survival and causes of death among women with EOC by histotype.

Methods

A population- based cohort including all ovarian cancer patients diagnosed in British Columbia (BC) between 1990 and 2014 was built using population-based administrative datasets. We compared causes of death within histotypes, by age at diagnosis, BRCA status, and time since diagnosis.

Results

A total of 6975 women were identified as having been diagnosed with EOC between 1990 and 2014 in BC. The most common cause of death among these women was ovarian cancer until 10 years post diagnosis when other causes surpassed ovarian cancer as the leading cause of death. Among women with serous EOCs, ovarian cancer was the leading cause of death 12 years after diagnosis, whereas ovarian cancer was the leading cause of death for 8 years among women with non- serous EOCs. Among women with serous EOCs, ovarian cancer was the leading cause of death for 12 years among younger women (< 60 years of age) compared to 8 years among women > = 60 years of age, and those with BRCA mutations were more likely to die from ovarian cancer than those without a BRCA mutation.

Conclusions

Within 10 years from diagnosis, ovarian cancer is the leading cause of death among women diagnosed with EOC.
Appendix
Available only for authorised users
Literature
1.
go back to reference Canadian Cancer Society's Advisory Committee on Cancer Statistics. Canadian Cancer Statistics 2014 - Special Topic: Skin Cancers. Canadian Cancer Society; 2014. http://www.cancer.ca/. Accessed 20 May 2017. Canadian Cancer Society's Advisory Committee on Cancer Statistics. Canadian Cancer Statistics 2014 - Special Topic: Skin Cancers. Canadian Cancer Society; 2014. http://​www.​cancer.​ca/. Accessed 20 May 2017.
2.
go back to reference Canadian Cancer Society's Advisory Committee on Cancer Statistics. Canadian Cancer Statistics 2016 - Special topic: HPV-associated cancers; 2016. http://www.cancer.ca/. Accessed 20 May 2017. Canadian Cancer Society's Advisory Committee on Cancer Statistics. Canadian Cancer Statistics 2016 - Special topic: HPV-associated cancers; 2016. http://​www.​cancer.​ca/. Accessed 20 May 2017.
19.
28.
Metadata
Title
Long-term mortality among women with epithelial ovarian cancer: a population-based study in British Columbia, Canada
Authors
Nimisha Arora
Aline Talhouk
Jessica N. McAlpine
Michael R. Law
Gillian E. Hanley
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-4970-9

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine